Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01928576 |
Title | Phase II Anti-PD1 Epigenetic Priming Study in NSCLC. |
Acronym | NA_00084192 |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Sidney Kimmel Comprehensive Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Southern California | Los Angeles | California | 90033 | United States | Details | |
Sibley Memorial Hospital | Washington | District of Columbia | 20016 | United States | Details | |
Julie Brahmer, MD | Baltimore | Maryland | 21224 | United States | Details | |
Julie Brahmer, MD | Baltimore | Maryland | 21287 | United States | Details | |
UPMC Cancer Center- Hillman Cancer Center | Pittsburgh | Pennsylvania | 15213 | United States | Details |